Acrivon Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-25-058352 |
2025-04-25 08:30:10 |
DEF 14A
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-016268 |
2023-05-01 16:23:14 |
DEF 14A
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000902664-23-001677 |
2023-02-14 09:35:53 |
SC 13G
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001104659-22-122435 |
2022-11-28 16:31:23 |
SC 13D
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001213900-22-075488 |
2022-11-28 15:59:24 |
SC 13G
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-22-292633 |
2022-11-25 16:25:29 |
SC 13G
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001104659-22-120743 |
2022-11-21 16:01:15 |
SC 13G
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-22-289031 |
2022-11-18 16:31:01 |
SC 13G
|
